Tris Pharma, Inc. v. Granules Pharmaceuticals, Inc.

Docket(#17) Letter to The Honorable Jennifer L. Hall from Alexandra M. Joyce, Esq. regarding Stipulated Scheduling Order. (Attachments: #1 Stipulated Scheduling Order)(Joyce, Alexandra) (Entered: 06/20/2025)

Docket(#16) NOTICE OF SERVICE of Plaintiff's First Set of Requests (Nos. 1-15) to Granules for the Production of Documents and Things filed by Tris Pharma, Inc..(Silver, Daniel) (Entered: 06/20/2025)

Docket(#15) SO ORDERED, re #14 Stipulation and Order Regarding Dismissal of Defendant's Fourth Defense. Signed by Judge Jennifer L. Hall on 6/18/2025. (ceg) (Entered: 06/18/2025)

Docket(#14) STIPULATION and [Proposed] Order Regarding Dismissal of Defendant's Fourth Defense by Tris Pharma, Inc.. (Joyce, Alexandra) (Entered: 06/13/2025)

Docket(#13) ANSWER to #10 Answer to Complaint, Counterclaim by Tris Pharma, Inc..(Silver, Daniel) (Entered: 06/06/2025)

DocketPro Hac Vice Attorney Jon T. Clark for Tris Pharma, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cdd) (Entered: 05/22/2025)

DocketPro Hac Vice Attorney Lisa B. Pensabene for Tris Pharma, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cdd) (Entered: 05/21/2025)

Docket(#12) ORAL ORDER: IT IS HEREBY ORDERED that, within thirty days, the parties shall jointly prepare and file the following: (i) a proposed Scheduling Order consistent with Judge Hall's "Rule 16 Scheduling Order - Patent", and (ii) a letter, not to exceed three pages, setting forth (a) a description of what this case is about; (b) the parties' positions regarding any disputes in the proposed Scheduling Order; and (c) a list of any other issues the parties want to address at the Rule 16 Scheduling Conference. Thereafter, the Court may schedule a Rule 16 Scheduling Conference to be held with Judge Hall. The Scheduling Order can be found on Judge Hall's portion of the District Court's website. Ordered by Judge Jennifer L. Hall on 5/20/2025. (ceg) (Entered: 05/20/2025)

DocketPro Hac Vice Attorney James Y. Li for Tris Pharma, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cdd) (Entered: 05/16/2025)

Docket(#11) Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Granules India Limited for Granules Pharmaceuticals, Inc. filed by Granules Pharmaceuticals, Inc.. (Dorsney, Kenneth) (Entered: 05/16/2025)

Docket(#9) Pro Hac Vice Fee - Credit Card Payment received for Lisa B. Pensabene, James Y. Li, Connie P. Lee, and Jon T. Clark. ( re #8 MOTION for Pro Hac Vice Appearance of Attorney Lisa B. Pensabene, James Y. Li, Connie P. Lee, and Jon T. Clark )( Payment of $ 200, receipt number ADEDC-4679799).(Silver, Daniel) (Entered: 05/06/2025)

Docket(#8) MOTION for Pro Hac Vice Appearance of Attorney Lisa B. Pensabene, James Y. Li, Connie P. Lee, and Jon T. Clark - filed by Tris Pharma, Inc.. (Attachments: #1 Certifications for Lisa B. Pensabene, James Y. Li, Connie P. Lee, and Jon T. Clark)(Silver, Daniel) (Entered: 05/06/2025)

DocketCase Assigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. (alb) (Entered: 04/30/2025)

Docket(#7) SUMMONS Returned Executed by Tris Pharma, Inc..Granules Pharmaceuticals, Inc. served on 4/25/2025, answer due 5/16/2025. (Joyce, Alexandra) (Entered: 04/28/2025)

Docket(#6) Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,590,081. (mpb) (Entered: 04/25/2025)

Docket(#5) Summons Issued as to Granules Pharmaceuticals, Inc. on 4/24/2025. (mpb) (Entered: 04/24/2025)

Docket(#4) Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Tris Pharma, Inc. (mpb) (Entered: 04/24/2025)

Docket(#3) Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/12/2025. Date of Expiration of Patent: 9/24/2038.Thirty Month Stay Deadline: No earlier than 9/12/2027. (mpb) Modified on 4/24/2025 (nms). (Entered: 04/24/2025)

Docket(#2) Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 04/24/2025)

Docket(#1) COMPLAINT for Patent Infringement against Granules Pharmaceuticals, Inc. (Filing fee $ 405, receipt number ADEDC-4669579) - filed by Tris Pharma, Inc. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(mpb) (Entered: 04/24/2025)